Literature DB >> 24217536

Different lesions revealed by 18F-FDG PET/CT and 18F-NaF PET/CT in patients with multiple myeloma.

Feng Xu1, Frank Liu, Behram Pastakia.   

Abstract

We present different findings on 18F-FDG PET/CT and 18F-NaF PET/CT images in 2 patients with multiple myeloma. In 1 case, 18F-FDG PET/CT showed intense uptake in the lesions in the axial skeleton where 18F-NaF PET/CT seemed normal. In addition, a sternal lesion showed FDG uptake only in the center but NaF uptake only in the periphery. In another patient, intense NaF accumulation in a dorsal vertebra was noted, but the corresponding FDG uptake was unimpressive. The role of these 2 radioactive tracers in the management of multiple myeloma continues to be defined.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24217536     DOI： 10.1097/RLU.0000000000000285

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN： 0363-9762            Impact factor:   7.794


  4 in total

1.  Quantitative analysis of 18F-NaF dynamic PET/CT cannot differentiate malignant from benign lesions in multiple myeloma.

Authors:  Christos Sachpekidis; Jens Hillengass; Hartmut Goldschmidt; Hoda Anwar; Uwe Haberkorn; Antonia Dimitrakopoulou-Strauss
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-09-01

2.  Treatment response evaluation with 18F-FDG PET/CT and 18F-NaF PET/CT in multiple myeloma patients undergoing high-dose chemotherapy and autologous stem cell transplantation.

Authors:  Christos Sachpekidis; J Hillengass; H Goldschmidt; B Wagner; U Haberkorn; K Kopka; A Dimitrakopoulou-Strauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-08-29       Impact factor: 9.236

3.  Prognostic significance of 18F-sodium fluoride in newly diagnosed multiple myeloma patients.

Authors:  Mahdi Zirakchian Zadeh; Siavash Mehdizadeh Seraj; Brian Østergaard; Stephanie Mimms; William Y Raynor; Mahmoud Aly; Austin J Borja; Leila S Arani; Oke Gerke; Thomas J Werner; Hongming Zhuang; Mona-Elisabeth Revheim; Niels Abildgaard; Poul Flemming Høilund-Carlsen; Abass Alavi
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-08-25

Review 4.  Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma.

Authors:  Christos Sachpekidis; Hartmut Goldschmidt; Antonia Dimitrakopoulou-Strauss
Journal:  Molecules       Date:  2019-12-29       Impact factor: 4.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.